Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

Overexpression of FGF receptor 3 (FGFR3) is implicated within the growth of t(4;14)-positive a number of myeloma. Whereas FGFR3 is steadily overexpressed and/or activated via mutations in bladder most cancers, the purposeful significance of FGFR3 and its potential as a particular therapeutic goal on this illness haven’t been elucidated in vivo. Right here we report…

Read More